Clopidogrel as an Antiplatelet Agent in Transplant Heart Coronary Stenting

Clopidogrel is increasingly used as an antiplatelet agent along with aspirin in coronary stenting due to its safety profile and clinical efficacy. This report describes a case of successful direct coronary stenting in a transplanted heart with the use of clopidogrel and aspirin therapy. Vessel paten...

Full description

Saved in:
Bibliographic Details
Published inJournal of interventional cardiology Vol. 15; no. 3; pp. 197 - 199
Main Authors MAHADEVAN, VAIKOM S., KHAN, MAZHAR M., ADGEY, JENNIFER A.A.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.06.2002
Subjects
Aspirin - therapeutic use
Coronary Thrombosis - prevention & control
Drug Therapy, Combination
Heart Transplantation
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors - therapeutic use
Stents - adverse effects
Ticlopidine - analogs & derivatives
Ticlopidine - therapeutic use
Treatment Outcome
Online AccessGet full text

Cover

More Information
Summary:Clopidogrel is increasingly used as an antiplatelet agent along with aspirin in coronary stenting due to its safety profile and clinical efficacy. This report describes a case of successful direct coronary stenting in a transplanted heart with the use of clopidogrel and aspirin therapy. Vessel patency was preserved with no evidence of in stent restenosis on 4‐month follow‐up angiography.
Bibliography:istex:0FA240D505618687B1B46E37CC7BA2A801EB8D03
ark:/67375/WNG-WHJ9FGRS-K
ArticleID:JOIC197
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0896-4327
1540-8183
DOI:10.1111/j.1540-8183.2002.tb01056.x